Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
Articles
Treatment Optimization for Patients With Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Future Treatment Landscape for Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Promising Late-Stage Trials in Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Targeted Therapy Versus IO for Relapsed/Refractory Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Novel Approaches for Relapsed/Refractory Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Management of Brain Metastases in Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
I/O Dosing Schedules in Metastatic Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Novel Therapies for Metastatic Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Systemic Therapy for Metastatic Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Adjuvant Therapy for Melanoma: Safety and Efficacy
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Adjuvant Therapy for Melanoma: Ongoing Studies of Interest
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Adjuvant Data Explored for Locally Advanced Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Neoadjuvant Data Explored for Locally Advanced Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
pCR and Neoadjuvant Therapy for Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Molecular Testing in Locally Advanced Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Identifying Patients for Neoadjuvant Melanoma Therapy
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Optimal Management of Locally Advanced Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Latest Updated Articles
Published: May 27th 2024 | Updated: September 13th 2024
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma
Published: August 22nd 2024 | Updated: August 29th 2024
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
Published: August 6th 2024 | Updated: August 19th 2024
Long-term Follow-up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer: A Prespecified Subgroup Analysis From the Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Published: September 17th 2024 | Updated: September 21st 2024
FDA Approves Adjuvant Ribociclib in HR+/HER2– Breast Cancer
